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ABSTRACT
The emergence of antibiotic resistance in human
pathogens has become a major threat to modern
medicine. The outcome of antibiotic treatment can
be affected by the composition of the gut. Accord-
ingly, knowledge of the gut resistome composition
could enable more effective and individualized treat-
ment of bacterial infections. Yet, rapid workflows for
resistome characterization are lacking. To address
this challenge we developed the poreFUME work-
flow that deploys functional metagenomic selections
and nanopore sequencing to resistome mapping. We
demonstrate the approach by functionally character-
izing the gut resistome of an ICU (intensive care unit)
patient. The accuracy of the poreFUME pipeline is
with >97% sufficient for the annotation of antibiotic
resistance genes. The poreFUME pipeline provides
a promising approach for efficient resistome profil-
ing that could inform antibiotic treatment decisions
in the future.
INTRODUCTION
It is estimated that every year 700,000 people die of resistant
infections (1). Antibiotic resistance by human pathogens
has become a major threat, in particular for hospitalized
patients (1,2). Bacterial infections by resistant pathogens
are also coupled with an increase in healthcare costs (3).
The gut microbiome comprises a diverse set of antibiotic
resistance genes whichmay impact antibiotic treatment out-
comes in at least two ways (4–6). First, the gut microbiome
can act as a reservoir of resistance genes that can be ac-
quired by infecting human pathogens leading to evolution
of resistance during infection. Indeed, a close evolution-
ary relationship between resistance genes in pathogens and
commensals has been found (7). Second, the gut resistome
impacts the extent to which the commensal microbiota is
affected by antibiotic treatment. Studies of preterm infants
and their response to antibiotic treatment suggest that the
collateral damage to the commensal microbiota can be pre-
dicted from the resistome status at the start of treatment
(8). Accordingly, there is an increasing interest in the devel-
opment of clinically applicable workflows that enable expe-
dited and comprehensive characterization of the gut resis-
tome. Unfortunately, given the diversity of antibiotic resis-
tance genes in the gut microbiota, sequencing based meth-
ods alone provide an incomplete way to representatively
characterize the gut resistome. Instead, functional metage-
nomic selections, which circumvent the culturing step of in-
dividual gut microbes, allow less biased interrogation of the
gut resistome (9).
The future diagnostics of the wholemicrobiome are likely
going to be important in order to minimize collateral dam-
age of antibiotic treatment on the gut microbiome and,
in addition, to limit resistance gene exchange. The general
principles for how to guide antibiotic therapy based on a re-
sistome characterization have not been established, largely
due to the lack of bioinformatics methods for characteriz-
ing the resistome.
Consequently, rapid resistome profiling using a
functional-metagenomic approach would be a viable
approach to guide personalized antibiotic treatment.
A functional metagenomic workflow consists of several
steps, of which the final step is the analysis of metagenomic
sequencing data (Figure 1) (10). Traditionally, sequencing
data was obtained using Sanger sequencing, (11,12), yet,
high-throughput sequencing technologies such as 454 py-
rosequencing (13) and Illumina sequencing (6,14) have been
applied to analyze functional metagenomic assays as well.
The PARFuMSpipeline based on Illumina datawas used to
profile the antibiotic resistome of soil and of the human mi-
crobiome (4,6,14), and PacBio SMRT data has been used to
sequence large metagenomic insert libraries (∼40 kb) from
fosmids (15). There are several challenges related to data
processing and annotation in functional metagenomic se-
lections. For Sanger sequencing, the data annotation is usu-
ally done on fragmented assemblies. In each Sanger set, con-
tigs can be closed by using primer walking. However, primer
walking is hardly feasible for high-throughputs datasets and
requires weeks to complete. Short-read sequencing based
on the Illumina platform offers a high-throughput method,
yet, contig assembly can be hampered by repetitive se-
quences in the original insert. A workflow based on PacBio
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Figure 1. Overview of the poreFUMEworkflow consisting of the construction and sequencing of a metagenomic library. Fecal DNA is extracted, purified,
fragmented and cloned into a shuttle vector. The library of plasmids is transformed in an Escherichia coli expression host and grown on selective media
supplemented with antibiotics, this process takes ∼24 h. The next day, DNA of the resulting colonies is extracted and barcodes are ligated using a PCR
reaction. PCR-amplified DNA is used as input for the sequencing library. This process takes ∼2 h. The sequencing library is loaded into the MinION
nanopore sequencer and run between 6 and 48 h. Finally, the obtained sequencing data is demultiplexed, error corrected, polished (20) and annotated
using the CARD database (21) in the poreFUME pipeline.
SMRT data circumvents such assembly challenges; how-
ever, this technology has a significant capital cost require-
ment, a large laboratory footprint and is technically de-
manding, limiting point of care applications (16). In con-
trast, nanopore sequencing may be able to address these
challenges enabling on site monitoring of resistomes in both
clinical and environmental settings.
Nanopore sequencing works by threading a DNA
molecule through a nanopore embedded in a membrane.
When a voltage is applied over the membrane, an ion cur-
rent is established and this current is modulated whenDNA
bases pass through the pore. This current-signal depends
on the identity of the base that resides in the pore and is
converted into a nucleotide sequence by downstream soft-
ware. Using the MinION, read lengths larger than 100 kb
have been reported (http://biorxiv.org/content/early/2015/
05/13/019281). The MinION has already been applied to
study various aspects related to antibiotic resistance and
infection microbiology, including determining the structure
and chromosomal insertion site of a bacterial antibiotic re-
sistance island in Salmonella Typhi (16), detection of car-
bapenemases and ESBL genes and their genomic location
in Gram-negative pathogenic isolates (17,18), and identifi-
cation of species and resistance profiles of Staphylococcus
aureus and Mycobacterium tuberculosis isolates (19). Yet,
nanopore sequencing has so far not been applied to profile
the resistome of a complex microbial community.
In this study, we developed the poreFUME workflow
to characterize the resistome of a clinical samples (Figure
1) using nanopore sequencing. Metagenomic expression li-
braries were constructed using fecal samples from a hospi-
talized patient as input. The libraries were selected on solid
media containing various antibiotics and DNA was ex-
tracted from the surviving clones expressing metagenomic
inserts conferring antibiotic resistance. The extracted DNA
was sequenced using nanopore sequencing. Finally, the se-
quence data was processed using the poreFUME computa-
tional pipeline, which demultiplexes the barcodes, increases
the data quality and annotates antibiotic resistance genes.
MATERIALS AND METHODS
Experimental work
Ethics statement. The protocol for this study was reviewed
and approved by the institutional review board of the Uni-
versity Medical Center Utrecht (Utrecht, The Netherlands)
under number 10/0225. Informed consent for fecal sam-
pling during hospitalization was waived. Written consent
was obtained for the collection of fecal samples after hospi-
talization.
Sample collection. Longitudinal fecal samples were col-
lected from a human adult who received ICU care at the
University Medical Center Utrecht in the Netherlands. The
subject was a patient who, after a surgical intervention, was
admitted to ICU. Five longitudinal feces samples were col-
lected upon admission, during ICU stay and eight months
after hospitalization and stored at −80◦C. During ICU
stay, the patient was treated with cephalosporins and flu-
cloxacillin intravenously and a suspension containing to-
bramycin (an aminoglycoside antibiotic) and colistin (a
polymyxin antibiotic) was delivered to the gut throughout
ICU stay as a prophylactic treatment aimed against gut col-
onization by nosocomial pathogens (22). DNA from feces
was extracted as described previously (23).
Construction of metagenomic libraries for functional selec-
tions. Construction of metagenomic libraries was done
following the protocol (24) with slight modifications. DNA
was fragmented using a Covaris shearer to an average size
of 2 kb. DNA was blunt-ended and phosphorylated using
an End-Repair kit (Epicentre, USA). Sheared DNA (138
l) was mixed with 20 l 10× End Repair buffer, 20 l 2.5
mM dNTP, 20 l 10 mM ATP and 2 l of End-It enzyme.
After incubation at 22◦C for 55 min, the end-repair reac-
tion was heat inactivated at 70◦C for 20 min. End-repaired
DNAwas size selected by electrophoresis. Agarose gel slices
selected from the size range 0.5–5 kb were purified using the
Gel Purification Kit (Fermentas, USA). Gel purified DNA
was ligated into vector pZE21-MCS-1 (25) using Fast-link
DNA ligase (Epicentre, USA). For this purpose, the con-
centration of gel-purified and end-repaired DNA insert was
adjusted to 200 ng/l. Ligation reaction was set up with
2.5 l of DNA inserts (200 ng/l), 0.5 l 10× Ligation
buffer, 0.25 l 10 mM ATP, 0.25 l dH2O, 0.5 l HincII
cut pZE21-MCS-1 vector (100 ng/l). The ligation mix-
ture was incubated at 22◦C for 16 h and finally heat inac-
tivated at 70◦C for 20 min. Three l of ligation reaction was
electroporated into 50 l electrocompetent Escherichia coli
Top10 cells (Invitrogen, USA). After electroporation in a
2 mm cuvette (2000 V, 25 F, 200R), cells were recovered
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in 1 ml SOC medium for 1 h at 37◦C. Determination of
the transformation efficiency was done by plating out 1 l
and 0.01 l of recovered cells onto LB agar plates contain-
ing 50 g/ml kanamycin (pZE21-MCS-1 vector contains
a selectable marker for kanamycin resistance) (25). Colony
forming units (CFUs) were counted after overnight incu-
bation at 37◦C. For each library, the insert size distribution
was estimated by gel electrophoresis of the PCR products
obtained by amplifying the insert using primers flanking the
HincII site of the multiple cloning site of the pZE21-MCS-
1 vector (pZE21 81 104 57C and pZE21 151 174rc 58C;
Supplementary Table S4) (24).
The size of each of the metagenomic libraries for func-
tional selection was determined by multiplying the average
PCR based insert size with the number of CFUs. The size
of the five metagenomic libraries for functional selection is
listed in Supplementary Table S1. The rest of the recovered
cells after transformation was inoculated into 10 ml of LB
broth supplemented with 50 g/ml kanamycin and grown
overnight at 37◦C, 180 rpm. The overnight cultures were
stored with 15% (v/v) glycerol at −80◦C.
Functional selection of antibiotic resistance clones. The
overnight cultures grown and stored at -80◦C allowed each
clone after transformation to amplify (e.g. total cell count
would increase from 5 × 105 CFU containing the plasmid
per ml to 5 × 108 CFU/ml after overnight incubation and
storage at −80◦C). Resulting amplification of the particu-
lar clone in the library was resolved by plating each library
∼100× coverage. That is, each unique clone in the library
was screened by plating out ∼100 copies. For each library,
clones carrying antibiotic resistance determinants were se-
lected by plating onto solid LB agar supplemented with one
of the seven antibiotics: tobramycin, spectinomycin, ampi-
cillin, cefotaxime, azithromycin, tetracycline or fosfomycin
at concentrations that were inhibiting the wild-type strain
(Supplementary Table S2). The CFU was determined after
overnight incubation at 37◦C (Supplementary Table S2).
Sequencing of antibiotic resistance clones. From each an-
tibiotic plate, a representative number of clones was selected
for sequencing and further analysis of antibiotic resistant
genes. Single colonies selected on antibiotic resistance plates
were picked up into 96-well plates (each of the 96 wells
contained 200 l LB broth supplemented with 50 g/ml
kanamycin). The selected clones were grown overnight at
37◦C. The clones were transferred using a 96-pin replicator
into new 96-well plates and onto squared LB agar plates
supplemented with 50 g/ml kanamycin. Single clones
from 96-well plates were Sanger sequenced by BeckmanGe-
nomics, UK with primers listed in table Supplementary Ta-
ble S4.
The clones from the individual square agar plates were
collected by adding 5 ml H2O, after which the colonies were
scraped off the plate with an L-shaped cell scraper. The
washing step was repeated twice to remove all the cells from
the plate. The bacterial cells were then pelleted by centrifu-
gation at 5000 g for 10 min. The supernatant was discarded
and the pellet was dissolved in 10 ml of H2O. Two ml of
the collected bacterial cells was used for plasmid extractions
with the Plasmid Mini Kit (Invitrogen, USA). The rest of
the cells were heat inactivated at 95◦C for 10 min and stored
as a bacterial cell pellet. For nanopore and PacBio sequenc-
ing, primers were synthesized that amplify the common re-
gion on pZE21-MCS- together with the specific barcodes
from PacBio (Supplementary Table S5). One ng of DNA
or 1 l of raw bacterial cell pellet was amplified by PCR.
Amplified and barcoded DNA was size selected by elec-
trophoresis. Agarose gel slices selected from the size range
1–5 kb were purified using Gel Purification Kit (Fermentas,
USA). In total 39 barcodes (1 and 11–48) were multiplexed
according to the scheme in Supplementary Table S7.
Nanopore sequencing library preparation. The nanopore
sequencing library B was prepared as briefly described be-
low. DNA QC was performed using Qubit dsDNA High
Sensitivity Assay Kit (Thermo Fisher Scientific, USA)
and 2200 TapeStation (Agilent, USA). Sequencing library
preparation was carried out with Nanopore Genomic Se-
quencing Kit SQK-MAP006 (Oxford Nanopore, UK) and
a PCR-free ‘native barcoding’ kit according to the manu-
facturer’s protocol. The NEBNext Ultra II End Repair/dA
Tailing module (E7546S, NEB, USA) was used to pre-
pare 1000 ng of the functionally selected DNA. End-
prepared DNA was ligated with native barcode adapters
NB04 fromOxford Nanopore using Blunt/TALigaseMas-
ter Mix (M0367S, NEB, USA). The resulting DNA was
pooled with 8 other unrelated barcoded libraries by equiv-
alent weight. The pooled sample was mixed with the ‘Na-
tive Barcoding Adapter Mix (BAM)’ and ‘Native Barcod-
ing Hairpin Adapter (BHP)’ together with Blunt/TA Lig-
ase Master Mix (M0367S, NEB, USA), and after incuba-
tionHP tether was added. The reactionmixture was cleaned
up using prewashed Dynabeads MyOne Streptavidin C1
(Thermo Fisher Scientific, USA).
The sequencing library A was prepared using the same
protocol as library B, but the native barcoding and pooling
steps were omitted.
Nanopore sequencing. The MinION was primed twice for
10 min with 500 l priming solution (250 l nuclease free
water, 237 l 2× Running Buffer, 13 l Fuel Mix). For se-
quencing, 6 l library was mixed with 65 l nuclease free
water, 75 l 2× Running Buffer and 4 l Fuel Mix (SQK-
MAP006, Oxford Nanopore, UK) and immediately loaded
to a MinION. The ‘SQK-MAP006 Scripts for Yield Moni-
toring Switch, Bias-Voltage Re-mux Tuning & Pore Shep-
herding’ by John Tyson (personal communication) were
used in the MinKNOW software to sequence the library.
Data analysis
Nanopore data processing. The sequencing data was base-
called using Metrichor. The Metrichor workflow for se-
quencing library A included additional native barcode de-
multiplexing. Poretools (26) was used to extract 2D reads
using the poretools fasta –type 2D command. Next the 2D
reads were analyzed using poreFUME.
poreFUME nanopore sequence analysis. The poreFUME
pipeline consists of four steps. First, the reads are demul-
tiplexed on barcode using the Smith-Waterman algorithm
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Figure 2. Barcode distribution of the 24 126 2D-reads nanopore library A (green) and control library B (3361 2D-reads, orange). The Pearson correlation
test (R2 = 0.75, P < 10−12) shows the significance of the log transformed abundance relationship between the two nanopore libraries.
(27). User defined barcodes are detected within 60 (Library
A) or 120 (Library B) basepairs of the read ends. Barcode
alignment was scored using +2.7 for match, −4.5 for mis-
match, −4.7 gap opening and −1.6 for gap extension. A
score threshold of >58 was used for the combined score of
the asymmetric barcodes. Second, the demultiplexed reads
were error corrected using the original nanocorrect protocol
(20). The original nanocorrect protocol implements a min-
imum read coverage of 3×, to ensure that only high-quality
data will be outputted. Since we were also interested max-
imizing sequence diversity, we adjusted the minimum cov-
erage to 1× in the second round of nanocorrect by modi-
fying the min coverage parameter from 3 to 1. In the third
step the nanocorrected sequences were polished using na-
nopolish (20). Briefly, the raw event data is mapped to the
nanocorrected sequences via BWA (28) and only nanocor-
rected reads with a mean raw read coverage of >30× are
used in the polishing step. Finally, only nanopolish pro-
posed mutations are accepted if >85% of the reads sup-
port this base. In the last step of poreFUME the error cor-
rected and polished reads were mapped against the CARD
database (21,29) using blastn (30) (version 2.4.0) with the
parameters max hsps 1 and max target seqs 1000. Closely
related genes such as blaTEM, blaCTX, mir and srt (ie. srt-1
and srt-2) were masked and only reported as the prototype
(i.e. srt). For each individual read, the BLAST hits were
sorted by bitscore and the highest scoring CARD hit on
each segment was kept. For successful CARD gene calling
two thresholds were set: a sequence identity of >80% and a
>50% coverage of the original gene in the CARD database.
It should be noted that we did not implement the Resis-
tance Gene Identifier (RGI) module of CARD (29). Since
RGI relies on open reading frame detection, we noticed that
ORF calling is not yet optimized for nanopore data (data
not shown), thus instead wemade use of the nucleotide data
in a blastn query.
Sanger sequence data analysis. The Sanger sequencing re-
sulted in 770 ‘forward’ and 779 ‘reverse’ sequencing reads.
Sanger DNA sequences were imported to CLC Genomic
Workbench (version 7.6.4). Sequences were vector and
quality trimmed (Q 0.01) and assembled using the ‘Assem-
ble Sequences’ module. Contigs with a length of<500 base-
pairs were omitted from further analysis.
PacBio data analysis. PacBio sequences were obtained
from theNorwegian Sequencing Centre at the University of
Oslo in two flowcells on the Pacific Biosciences RS II instru-
ment using P6-C4 chemistry. Themetrics for the total set are
listed in SupplementaryTable S6.RawPacBio data from the
flowcells was analyzed with PacBio SMRT® Portal version
2.3.0 and reads were extracted using the RS ReadsOfInsert
protocol (version 2.3.0). The RS ReadsOfInsert protocol
was run with a minimum predicted accuracy of 99, and
minimum read length of insert length of 100 bp. Addition-
ally, paired-end barcode detection was performed using the
pacbio barcodes paired scheme containing 48 unique bar-
code pairs. Aminimumbarcode score of 15was used in both
cells. The extracted reads of insert were grouped by indi-
vidual barcode and exported in the fastq. The final yield is
reported in Supplementary Table S5.
PacBio reads were collapsed with Pbdagcon (https://
github.com/PacificBiosciences/pbdagcon, version f19aed1)
using dazcon with the flags –only-proper-overlaps and –
coverage-sort and parameter –min-coverage 0.
The integron structure was annotated using blastn and
IntegronFinder (31).
RESULTS
We constructed metagenomic expression libraries from fe-
cal samples obtained from an Intensive Care Unit (ICU)
patient as described in (24) (Materials and methods).
The library size ranged between 2.9 and 8.8 × 108 bp
of DNA (Supplementary Table S1). The metagenomic li-
braries were plated on solid LB agar media containing
inhibitory concentrations of the antibiotics: tobramycin,
spectinomycin, ampicillin, cefotaxime, azithromycin, tetra-
cycline or fosfomycin (Supplementary Table S2). Clones
from themetagenomic libraries able to tolerate each of these
seven different antibiotics were detected in all libraries (Sup-
plementary Table S2). From each antibiotic plate a rep-
resentative number of clones were selected (in total 864),
pooled, barcoded with custom adapters using PCR and
prepared for sequencing using the MinION nanopore se-
quencer (Materials and methods).
Nanopore sequencing yielded 95.1Mbase in 62 890 high-
quality ‘passing filter’ two-direction (2D) reads with amean
length of 1513 bp (library A) (Supplementary Figure S1).
As an internal control, we multiplexed the sequencing li-
brary with eight other unrelated samples (library B). Due
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Figure 3. Distribution of the occurrence of the 26 different CARD genes
found in the PacBio and nanopore dataset. The Pearson correlation test
(R2 = 0.71, P < 10−7) showed a significant relationship between the
nanopore and PacBio dataset as assessed by the log-transformed propor-
tion of CARD hits found. Threshold for CARD identification are gene
coverage of >50% and >80% sequence identity.
Figure 4. Abundance of 26 CARD genes in the PacBio (blue) and
nanopore (green) dataset as show as fraction of the total reads contained in
each dataset. The threshold for CARD identification are a gene coverage
of >50% and >80% sequence identity.
to multiplexing with unrelated samples, library B generated
only 4959 sample specific 2D reads (Supplementary Table
S3). The subsequent part of this study focuses exclusively
on the use of high-quality ‘passing filter’ 2D reads.
The first step of poreFUME is to demultiplex the bar-
codes. We identified all the 39 experimentally attached bar-
codes in both the nanopore sequencing libraries (Figure
2). The abundance showed a significant correlation of log
transformed abundance with the Pearson correlation test
(R2 = 0.75, P < 10−12) between the two libraries, high-
lighting the reproducibility of the sequencing and bar-
code demultiplexing step. Due to the smaller library size
of nanopore library B the remainder of this study focuses
on nanopore library A. A Pearson correction test of the
barcode abundance between nanopore library A and the
PacBio library resulted in a R2 of 0.42 (P< 10−5) as shown
in Supplementary Figure S4. This lower correlation might
be due to a PacBio sequencing bias, as the PacBio instru-
ment preferably loads shorter DNA fragements (32), this is
supported by a mean read length of nanopore library A of
1513 bp versus 1370 bp for the PacBio library (Supplemen-
tary Table S3).
The sequencing data obtained with MinION nanopore
R7 chemistry has an 2D read accuracy of ∼85% (20). This
relative high error rate can be mitigated using error cor-
rection, with tools such as nanocorrect (20). Nanocorrect
is implemented as second step in the poreFUME pipeline.
Nanocorrect has been applied previously to increase the
nanopore read accuracy from 80.5% to 95.9% (20). The
algorithm identifies overlapping reads using DALIGNER
(33) and calculates a consensus sequence, using partial-
order alignment (POA) software (34). Two rounds of error
correction where conducted by the poreFUMEpipeline. Fi-
nally, the error corrected reads were polished using nanopo-
lish (20) which uses the raw nanopore event data to increase
the accuracy.
We annotated the error corrected and polished sequenc-
ing data for the presence of antibiotic resistance genes us-
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Figure 5. Histogram of the sequence identity of the 2D nanopore sequence reads of library A (12 820 reads) after two rounds of error correction and
polishing, showing a mean sequence identity to the Sanger data set of 98.0%. The PacBio dataset after a single round of consensus calling using pbdagcon
(3086 reads) shows a mean sequence identity to the Sanger dataset of 99.3%.
A B
Figure 6. (A) Example of CARD genes found in the nanopore dataset that were plated on spectinomycin. Of the 244 nanopore reads that were recovered
on spectinomycin, all contain the aadA,which encodes an aminoglycoside nucleotidyltransferase known to confer resistance to spectinomycin. In 126 reads
aadA is flanked by dfrA1, which confers resistance to trimethoprim and in 74 reads aadA is flanked by sat-1 which confers resistance to streptothricin.
The genes sat-1 and dfrA1 do not confer known resistance to spectinomycin and are thus co-selected with aadA. (B) Alignment against the NT database
of the longest corrected nanopore read of the 126 reads containing aadA and dfrA obtained from functional selection on spectinomycin. The corrected
nanopore read shares 99% sequence identify with the two top scoring hits in the NT database: (light gray) integron from Salmonella enterica subsp.
enterica serovar (GenBank: HQ132378.1) and the E. coli plasmid pH1038-142 (genbank: KJ484634) described by Wang et al. (38). The attC region is a
repeat sequence which typically flanks a resistance cassette, dfrA encodes a dihydrofolate reductase known to confer resistance against trimethoprim, aadA
is an aminoglycoside nucleotidyltransferase known to confer resistance to spectinomycin and ybeA (also known as orfX) which is a pseudocassette and
present as conserved 3′ fragment in class 2 integrons (36).
ing Comprehensive Antibiotic Research Database (CARD)
(21). Using the CARD database, 26 different antibiotic re-
sistance genes were identified in the nanopore data set (Fig-
ure 4). A variety of antibiotic resistance genes were detected
with a mean sequence identity of 97.3%, including beta
lactamase genes (blaCTX-M, blaTEM and cblA), genes cod-
ing aminoglycoside modifying proteins (from different sub-
classes of AAC, ANT and APH enzymes) and diverse genes
encoding ribosomal and efflux mediated resistance towards
tetracycline antibiotics, among others (Figure 3 and Supple-
mentary Figure S3). Antibiotic resistance databases such as
CARD are commonly used to identify antibiotic resistance
genes in metagenomic sequencing data (35). Yet, based on
our observation 33.8% inserts had no identifiably match in
CARD, indicating the further potential for discoveries of
novel antibiotic resistance genes from the human gut (Fig-
ure 5).
To validate the nanopore sequencing results, we se-
quenced the same barcoded DNA using PacBio SMRT
technology yielding 93.5 Mbase of DNA in 68 144 reads
(with >99% accuracy) from two sequencing cells. After an-
notation with the CARD database, we observed that the ex-
act same set of 26 antibiotic resistance genes detected in the
nanopore dataset were also present in the PacBio dataset
(Figure 4). The mean sequence identity of the genes iden-
tified in the CARD database is for the PacBio dataset with
97.8% slightly better than that of the error-corrected and
polished nanopore dataset with 97.3% (Supplementary Fig-
ure S2). The abundance of reads between the nanopore and
PacBio dataset was in good agreement as calculated using
the Pearson correlation test (R2 = 0.71, P < 10−7) (Figure
3).
To further test the accuracy of our nanopore data set,
we sequenced the selected libraries using Sanger sequenc-
ing. The sequence identity between the Sanger reads and the
non-corrected 2D reads of nanopore library A was 85.8%
(Supplementary Figure S2), this confirms the higher error
rate of the used MinION reads (16,20). However, by using
two rounds of error correction and polishing implemented
by poreFUME the sequence identity of the nanopore reads
was improved from 86.8% to 98.0%, which enables accurate
resistome mapping using CARD.
Nanopore reads are longer and typically capture the en-
tire metagenomic insert. In this way, analysis of the con-
text of the antibiotic resistance gene is simplified. As an ex-
ample to link genotype and phenotype we investigated the
244 nanopore reads that were selected on plates containing
spectinomycin and resulted in a CARD annotation. All the
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244 reads contain the aadA gene which encodes an amino-
glycoside nucleotidyltransferase known to confer resistance
to spectinomycin (Figure 6A). In 74 reads aadAwas flanked
by sat-1 which encodes a streptothricin acetyltransferase
and confers resistance to streptothricin. The sat-1 gene is
likely co-selected with aadA. In 44 reads the aadA was the
only gene detected, however in 126 reads aadA was flanked
by dfrA1. The dfrA1 gene confers resistance to trimetho-
prim and is not known to confer resistance to spectino-
mycin. Alignment of the longest nanopore read containing
both dfrA1 and aadA against the NT database showed that
the two highest scoring hits are part of an integron (Fig-
ure 6B). Furthermore, two attC sites are detected (31) and
an ybeA gene cassette (part of the 3′ conserved fragment
of class 2 integrons (36)) is found. Nanopore sequencing
is thus able to identify such differing contexts of antibi-
otic resistance genes, which can impact the probability of a
pathogen to acquire specific antibiotic resistance genes (37).
DISCUSSION
Hospital settings, including ICUs, are hotspots for the
emergence and selection for antibiotic resistant organisms.
In this study, we successfully applied nanopore sequencing
to characterize the gut resistome of an ICU patient using
metagenomic functional selections. Nanopore sequencing
currently has a higher error rate compared to short-read
Illumina sequencing; however, implementing a double er-
ror correction and polishing scheme in poreFUME we are
able to achieve accuracies >98%, which enables reliable re-
sistance gene annotation and comparable results to that of
PacBio SMRT sequencing at considerable lower costs. In
this study, both sequencing platforms enabled the reliable
identification of 26 unique antibiotic resistance genes. This,
along with the rapid turnaround time of the poreFUME
workflow, suggests that it could be applied as a possible re-
sistome monitoring tool.
A benefit of nanopore sequencing is the resulting long
reads. Since the sequence analysis is often hampered by as-
sembly of short reads, for example in previous efforts only
50% of the functionally selected clones could be fully as-
sembled (15). Other methods, such as ParFUMS, require
several assembly steps and the use of custom scripts, which
hamper the uptake of this method by the scientific commu-
nity (4,6,14).
Only 39% of the nanopore 2D reads had their barcodes
successfully demultiplexed in this study. Improvements
to the protocol can be made by making use of barcodes
with a larger editing distance. In accordance, the cur-
rently used barcodes are deprecated and replaced by a
set with a larger editing distance, which allows for bet-
ter separation and a higher barcode identification rate
(https://github.com/PacificBiosciences/Bioinformatics-
Training/wiki/Barcoding#barcode-sequences). However,
even the 61% loss due to barcode demultiplexing does not
hamper downstream resistome analysis using poreFUME.
The current data is generated using the R7.3 sequenc-
ing pore in kit SQK-MAP006. However, recent develop-
ments in nanopore sequencing technologies (R9 pore) re-
sulted in 2D accuracies of >90%. This increase in R9 read
accuracy (compared with 86% of 2D R7.3) would therefore
contribute to the accuracy of the poreFUME annotation.
CONCLUSION
In conclusion, the poreFUME pipeline provides a promis-
ing alternative to other next-generation sequencing alterna-
tives (6,15) and can be used to rapidly profile the resistome
of both environmental and gut microbial communities (4–
6). We foresee that rapid resistome profiling tools such as
poreFUME could aid the implementation of personalized
antibiotic treatment in high risk patients.
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Supplementary Data are available at NAR Online.
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